Atrayee Basu Mallick

Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis

Kamil M. Amer, Murty Munn, Dominick V. Congiusta et al. · Journal of Orthopaedic Research® · 2019 · 115 citations · Full text

Abstract CT124: A phase Ib/II study of BMS-813160, a CC chemokine receptor (CCR) 2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients (pts) with advanced pancreatic or colorectal cancer

Dung T. Le, Martin Gutierrez, Mansoor N. Saleh et al. · Cancer Research · 2018 · 28 citations

Immunology, Immunoediting, Pathology +21

A phase III study (APROMISS) of AL3818 (Catequentinib, Anlotinib) hydrochloride monotherapy in subjects with metastatic or advanced synovial sarcoma.

Brian Andrew Van Tine, Sant P. Chawla, Jonathan C. Trent et al. · Journal of Clinical Oncology · 2021 · 25 citations

Surgical Oncology, Pharmacotherapy, Pre-clinical Pharmacology +18

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

Shivaani Kummar, Lin Shen, David S. Hong et al. · Cancer · 2023 · 22 citations · Full text

Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma

Brandon M. Huffman, Atrayee Basu Mallick, Nora Horick et al. · JAMA Network Open · 2023 · 19 citations · Full text